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Abstract 
Background: Quantifying gametocyte densities in natural malaria infections is important to estimate malaria 
transmission potential. Two molecular methods (Pfs25 mRNA quantitative reverse transcriptase PCR (qRT-PCR) and 
Pfs25 mRNA quantitative nucleic acid sequence based amplification (QT-NASBA)) are commonly used to determine 
gametocyte densities in clinical and epidemiological studies and allow gametocyte detection at densities below the 
microscopic threshold for detection. Here, reproducibility of these measurements and the association between esti-
mated gametocyte densities and mosquito infection rates were compared.
Methods: To quantify intra- and inter-assay variation of QT-NASBA and qRT-PCR, a series of experiments was per-
formed using culture-derived mature Plasmodium falciparum gametocytes from three different parasite isolates (NF54, 
NF135, NF166). Pfs25 mRNA levels were also determined in samples from clinical trials in Mali and Burkina Faso using 
both methods. Agreement between the two methods and association with mosquito infection rates in membrane 
feeding assays were assessed.
Results: Intra- and inter-assay variability was larger in QT-NASBA compared to qRT-PCR, particularly at low gameto-
cyte densities (< 1 gametocyte per μL). Logistic models, including log-transformed gametocytaemia estimated by 
QT-NASBA, explained variability in mosquito feeding experiment results as well as log-transformed gametocytaemia 
by qRT-PCR (marginal R2 0.28 and 0.22, respectively). Densities determined by both methods strongly correlated with 
mosquito infection rates [Spearman’s rank correlation coefficient, 0.59 for qRT-PCR and 0.64 for QT-NASBA (P < 0.001 
for both)]. Gametocyte densities estimated by qRT-PCR were higher than levels estimated by QT-NASBA or light 
microscopy at high densities (>100 gametocyte per μL). Samples collected in one of the two transmission studies had 
extremely low gametocyte densities by both molecular methods, which is suggestive of RNA degradation due to an 
unknown number of freeze–thaw cycles and illustrates the reliance of molecular gametocyte diagnostics on a reliable 
cold-chain.
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Background
The transmission of malaria from humans to mosquitoes 
requires the presence of mature sexual stage parasites 
(gametocytes) in the peripheral blood. Upon inges-
tion by Anopheles mosquitoes and following sporogonic 
development, these gametocytes can render mosquitoes 
infectious to humans. Quantifying the density of these 
gametocytes in the peripheral blood is a fundamental 
part of estimating the infectiousness of individuals with 
malaria infections. For over a century, light microscopy 
was the only method available to quantify malaria para-
sites, including gametocytes. The development of sen-
sitive molecular methods has uncovered some of the 
limitations of microscopy. In endemic areas, a substantial 
proportion of infected individuals carry parasites at lev-
els below the microscopic threshold of detection [1–4], 
and many of these individuals also have low, sub-micro-
scopic, densities of gametocytes [5, 6]. Together with 
early observations that individuals with no gametocytes 
detected by microscopy could be infectious to Anopheles 
mosquitoes [7], these studies suggest that the use of more 
sensitive methods is necessary to characterize the infec-
tious reservoir of malaria [8, 9].
The most widely used target for molecular gametocyte 
detection and quantification is Pfs25 mRNA [9], which 
is gametocyte-specific and highly conserved among dif-
ferent parasite isolates [6]. Although expression of Pfs25 
mRNA is upregulated in female gametocytes [10], the 
female-biased gametocyte sex ratio and the high abun-
dance of Pfs25 mRNA relative to the male specific marker 
Pfs230p make it an attractive target for sensitive gameto-
cyte detection and quantification [11].
Various molecular techniques have been used for 
gametocyte detection and quantification. For Pfs25 
mRNA there are two commonly used protocols, one 
based on quantitative reverse transcriptase PCR (qRT-
PCR) and another based on quantitative nucleic acid 
sequence based amplification (QT-NASBA) [6, 12]. 
Although previous studies on other malaria-specific 
targets suggest that the accuracy, precision and opera-
tional attractiveness may differ between assays [13], QT-
NASBA and qRT-PCR, as currently routinely used, have 
never been directly compared for Plasmodium falcipa-
rum gametocyte quantification. Additionally, differences 
in Pfs25 transcript levels between malaria parasite strains 
have been hypothesized but never directly examined [14].
Here, Pfs25 mRNA QT-NASBA and qRT-PCR were 
compared for intra- and inter-assay variation using 
gametocytes from three different isolates [6, 12]. The 
association between gametocyte densities estimated by 
these two molecular methods in natural malaria infec-
tions and infectiousness quantified by membrane feeding 
assays was also determined.
Methods
Study design
In this study, both parasite culture-derived samples and 
samples from naturally infected individuals were used. 
For the estimation of intra-assay variation for both QT-
NASBA and qRT-PCR, culture-derived mature P. fal-
ciparum gametocytes at known densities were assayed 
in triplicates on the same 96-well plate with the same 
reaction mixtures. For the inter-assay variation analy-
sis, gametocyte dilution series were tested on separate 
plates and with separately prepared reaction mixtures. 
Samples collected from naturally infected individuals 
living in malaria-endemic regions were used to assess 
the correlation between gametocyte levels measured 
by microscopy, qRT-PCR and QT-NASBA and human 
infectiousness to mosquitoes, determined by mosquito 
feeding experiments.
Gametocyte culture
Plasmodium falciparum gametocytes from three labora-
tory parasite strains (NF54, NF135, NF166) were cultured 
in shaker flasks, as previously described [15–17]. Briefly, 
asexual blood stage parasites were reseeded at 5% haema-
tocrit (erythrocytes provided by healthy Dutch donors 
with blood type A) and 0.5% parasitaemia in culture 
medium containing RPMI 1640 with HEPES (5.94  g/L), 
hypoxanthine (0.05  g/L), 10% (v/v) pooled human sera 
(also blood type A) obtained from malaria-naive indi-
viduals, and 0.2% (w/v) sodium bicarbonate. Culture 
medium was automatically changed twice a day, and 
on day 4, 50  mM of N-acetylglucosamine was added in 
order to prevent the next generation of merozoites from 
infecting new erythrocytes. Gametocytes were allowed to 
mature until day 14.
Gametocyte dilution series
On day 14, mature gametocytes were harvested and Per-
coll purified according to the protocol described in Kariuki 
Conclusions: The experiments indicate that both qRT-PCR and QT-NASBA are of value for quantifying mature game-
tocytes in samples collected in field studies. For both assays, estimated gametocyte densities correlated well with 
mosquito infection rates. QT-NASBA is less reproducible than qRT-PCR, particularly for low gametocyte densities.
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et al. [18]; 63%, instead of 65%, Percoll gradient was used. 
Cultures and material used for purification were continu-
ously kept at 37  °C to avoid gametocyte activation. Fol-
lowing Percoll purification, gametocytes were counted 
by a single reader using a haemocytometer and diluted 
in whole blood at densities of 103, 102, 101, 100, 10−1, and 
10−2 or 5 × 103, 5 × 102, 5 × 101, 5 × 100, 5 × 10−1, and 
5  ×  10−2 gametocytes per µL. Fifty µL aliquots of each 
dilution were further diluted in 250 µL of RNAprotect Cell 
Reagent (Qiagen) when analysing standard curve tripli-
cates and samples collected in Burkina Faso (see below) or 
in 450 µL of L6 buffer when analysing samples collected in 
Mali, and stored at −80 °C until further use [19].
Samples from naturally infected individuals in clinical trials
Blood samples from patent gametocyte carriers were col-
lected during clinical trials in Mali and Burkina Faso [20, 
21]. In the study undertaken in Mali, male participants 
with at least 32 gametocytes per μL of blood based on 
gametocyte enumeration against 500 white blood cells 
(WBC), assuming 8000 WBCs/µL, were recruited. The 
trial in Burkina Faso had as an inclusion criterion the 
presence of at least one microscopically detectable game-
tocyte at screening slides, where 100 microscopic fields 
were examined. In both studies, blood samples were 
taken at multiple time-points, before and after treat-
ment initiation, to assess gametocyte clearance. Samples 
[venous blood in EDTA (Mali) or heparin (Burkina Faso) 
vacutainer] taken before initiation of anti-malarials were 
used in the current study. In Burkina Faso, 50 µL aliquots 
of blood were transferred into 250  µL of RNAprotect 
Cell Reagent. In Mali, 100 µL of blood were transferred 
into 900 µL of L6 buffer. Both sets of samples were kept 
at −80 °C until shipment, although the samples collected 
in Burkina Faso may have been exposed to freeze–thaw 
due to power-cut of unknown duration during politi-
cal unrest in November 2014. For both studies, sam-
ples were shipped in dry ice at controlled temperature 
(−70 to −80 °C) to Radboud University Medical Centre 
(Nijmegen, The Netherlands), where the laboratory work 
was performed.
For all samples, total nucleic acids (NA) were extracted 
using a MagNAPure LC automatic extractor (Total 
Nucleic Acid Isolation Kit–High Performance, Roche 
Applied Science) and eluted into 50 µL of elution buffer; 
while all of the 300  µL of samples collected in Burkina 
Faso were extracted, only half of the volume (500 µL of 
the 1 mL) of samples collected in Mali were used for total 
NA extraction.
Mosquito membrane feeding experiments
All individuals whose samples were included in this 
analysis participated in mosquito feeding experiments: a 
small quantity of heparinized venous blood (400–500 μL) 
was offered to female Anopheles gambiae mosquitoes 
(180 mosquitoes in the Mali study and 60 in the Bur-
kina Faso study) through a membrane [20–22]. Fully fed 
mosquitoes at the end of each experiment were selected, 
kept for one week on glucose at 27–29  °C to allow for 
parasite development, and dissected. In both studies, 
light microscopy was used to detect oocysts on the mid-
gut wall, and their presence was confirmed by a second 
microscopist. The proportion of mosquitoes with at least 
one oocyst was used as outcome measure.
Pfs25 mRNA qRT‑PCR
The use of reverse transcriptase PCR (RT-PCR) for the 
detection of Pfs25 mRNA was first described by Babiker 
et al. [23]; recently it was further developed into a qRT-
PCR [6]. Here, a protocol described by Schneider et  al. 
was used [11] with primers designed by Wampfler et al. 
[6]. Briefly, total NA extraction was followed by RQ1 
DNaseI digest (Promega) and cDNA synthesis (High 
Capacity cDNA Reverse Transcription Kit, Applied Bio-
systems). The DNase treatment and the RT-step were 
done once for each sample; the qPCR step was done in 
triplicate for samples included in the intra-assay varia-
tion analysis. Success of the DNase treatment was tested 
by performing qPCR, with the same primers, on two to 
five randomly selected samples of each plate (in total 35 
samples) before proceeding to the RT-step. No residual 
genomic DNA was detected in these assays, which indi-
cates successful DNase treatment. PCR conditions were 
according to manufacturer’s instructions, described as 
standard cycling programme of GoTaq® qPCR Master 
Mix (Promega). qRT-PCR cycle of threshold (Ct) val-
ues (the cycle at which the fluorescence signal crosses a 
pre-determined threshold during the exponential phase 
of the amplification) were obtained using CFX96™ Real-
Time PCR Detection System (BIO-RAD). For samples 
from naturally infected individuals, Ct values were con-
verted into gametocyte density using plate-specific stand-
ard curve. Samples with estimated densities below 0.02 
gametocytes per µL or 1 gametocyte per 50 µL of sam-
ple were considered negative. At the highest density of 
the gametocyte dilution series, cDNA corresponding to 
363.6 gametocytes was estimated to have been included 
in qRT-PCR reactions (Additional file 1: Figure S1).
Pfs25 mRNA QT‑NASBA
QT-NASBA was performed as in Schneider et  al. [12]. 
KCl concentrations in experiments performed for this 
study varied from 50 to 60  mM, and differed from the 
concentration used in the original protocol (80 mM) [12]. 
For samples from the Burkina Faso study, the extracted 
total NA used for qRT-PCR was also used for QT-NASBA 
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(before DNase treatment and cDNA production). For 
samples collected in the Mali trial, different aliquots of 
the same sample were extracted (total NA) and used for 
the different molecular assays; the QT-NASBA aliquot 
did not undergo DNAse treatment and cDNA produc-
tion. QT-NASBA results are expressed as time to positiv-
ity (TTP), as in this method amplification happens at a 
constant temperature, not in cycles. Standardized man-
ual thresholds to remove background noise are set at the 
begin value of 3 min and the end value of 15 min. As with 
qRT-PCR, gametocyte densities were assigned based 
on plate-specific gametocyte dilution series, which was 
diluted in whole blood before extraction of total NA. For 
samples from infected individuals, estimated gametocyte 
densities below 0.02 gametocytes per µL were considered 
to be negative. At the highest density of the gametocyte 
dilution curve, total NA corresponding to 2500 gameto-
cytes was estimated to have been included in QT-NASBA 
reactions (Additional file 1: Figure S1).
Statistical analysis
Analyses were conducted using STATA version 12 (Stata 
Corporation, College Station, TX, USA) and R (R Foun-
dation for Statistical Computing, Vienna, Austria).
Intra-assay variation was assessed by estimating coef-
ficients of variation (CV, expressed in %) (i.e., stand-
ard deviation divided by mean, and multiplied by 100) 
for each level of gametocytaemia tested in triplicate, in 
culture-specific gametocyte dilution series. Gametocyte 
dilution series were also used to quantify inter-assay vari-
ation: CV was estimated for each gametocyte density for 
all series tested in different reaction plates. To analyse the 
agreement between qRT-PCR- and QT-NASBA-defined 
gametocyte levels in samples from infected individuals 
in the Mali study, a Bland–Altman plot was constructed, 
whereby differences between densities assigned by these 
two methods are presented by the average assigned level. 
Generalized linear mixed models, with study partici-
pant as random effect, were fit to assess the association 
between mosquito infection status in feeding assays and 
gametocyte densities (fixed effect) assigned by these two 
molecular methods. For each quantification method, 
Akaike information criterion was used to select gameto-
cyte density scale (linear or logarithmic) in the models. 
Marginal R2, variance explained by fixed effects, was esti-
mated using the ‘r.squaredGLMM’ function in MuMIn 
package in R [24].
Results
Intra‑assay variation
Plasmodium falciparum gametocytes of the NF54, 
NF135 and NF166 strains were used to prepare dilution 
series with 103, 102, 101,100, 10−1, and 10−2 gametocytes 
per μL. Additionally, for the NF54 strain, samples origi-
nating from three different culture flasks were tested. 
For each gametocyte density of individual dilution series, 
Pfs25 mRNA expression was analysed in triplicate, using 
both qRT-PCR and QT-NASBA.
In Fig.  1 (panels a, b), TTP and Ct values for QT-
NASBA and qRT-PCR, respectively, are presented. For 
both assays, Pfs25 mRNA was not detected at the low-
est gametocyte densities (0.01 gametocytes per µL) of 
the NF135 and NF166 dilution series. Although results 
from dilution series appeared comparable between all 
three P. falciparum strains, the failure to detect the low-
est gametocyte concentration for NF135 and NF166 
might indicate lower Pfs25 transcript levels compared to 
the NF54 strain that only affects detection and quantifi-
cation at extremely low densities. Additionally, in 5/15 
0.10-gametocytes-per-µL samples, Pfs25 mRNA was 
not detected by qRT-PCR. In samples where amplified 
Pfs25 transcript was detected CV were inversely related 
to gametocyte levels and much lower for qRT-PCR com-
pared to QT-NASBA at all gametocyte densities.
Inter‑assay variation
Seven (including the following densities 5 × 103, 5 × 102, 
5 × 101, 5 × 100, 5 × 10−1, and 5 × 10−2 gametocytes per 
μL) and ten (including the densities 103, 102, 101,100, 10−1, 
and 10−2 gametocytes per μL) gametocyte dilution series, 
each tested on a different plate, were used to assess QT-
NASBA and qRT-PCR inter-assay variation, respectively. 
Only NF54 strain parasite cultures were used in these 
experiments. Samples with the lowest density in each 
series were often negative for Pfs25 mRNA. Despite the 
higher densities used for the QT-NASBA versus qRT-PCR 
dilution series, a similar pattern to the intra-assay variation 
experiments was observed (Fig.  1, panels g, h): CV were 
considerably higher for QT-NASBA compared to qRT-
PCR and decreased with increasing gametocyte densities.
Gametocyte densities in naturally infected individuals
Blood samples collected prior to treatment from game-
tocytaemic individuals participating in mosquito feed-
ing experiments in Mali were analysed by microscopy, 
qRT-PCR and QT-NASBA. For the two molecular assays, 
gametocyte densities were estimated based on dilution 
series of culture-derived P. falciparum gametocytes of the 
NF54 strain tested in the same plate, as routinely done 
[5, 12]. As a consequence of enrolment criteria, all indi-
viduals (N = 73) had microscopically detectable gameto-
cytes at the time of the feeding assay (median (IQR) 80 
(64–112) gametocytes per μL), and all their samples were 
assigned gametocyte levels above the threshold of posi-
tivity for both molecular assays (minima gametocyte lev-
els were 0.04 and 6.1 gametocytes/µL for qRT-PCR and 
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Fig. 1 Intra (a–d) and inter (e–h) assay variation of QT-NASBA and qRT-PCR. In a–d, different colours represent different strains and cultures used for 
intra-assay variation assessment. In e–h, different experiments used in the inter-assay variation assessment are represented by different colours. Time 
to positivity (TTP) values for samples tested by QT-NASBA are presented in a and e and coefficients of variation (CVs), in c and g. Cycle of threshold 
(Ct) values for samples tested by qRT-PCR are presented in b and f; CVs are presented in d and h. In a, b, e and f, circles outside the y-axis range cor-
respond to samples where Pfs25 mRNA was not detected. Of note, for experiments included in inter-assay variation analysis, different densities were 
used in gametocyte dilution series for QT-NASBA and qRT-PCR
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QT-NASBA, respectively). Median (IQR) gametocytae-
mias estimated by QT-NASBA and qRT-PCR were simi-
lar: 94.8 (41.6–180.7) and 69.8 (29.8–263.0) gametocytes 
per μL, respectively. The agreement between microscopy 
and QT-NASBA, between microscopy and qRT-PCR and 
between the two molecular methods was assessed by 
Bland–Altman plots (Fig. 2). At high gametocyte concen-
trations (>100 gametocytes per μL), gametocyte densities 
estimated by qRT-PCR were higher than densities esti-
mated by microscopy or QT-NASBA.
In the same study in Mali, 73 membrane feeding assays 
were performed. The median (IQR) number of mos-
quitoes fed and dissected was 176 (174–177) and 142 
(130–152), respectively. Overall 58/73 (79.4%) individu-
als infected at least one mosquito, and the median (IQR) 
mosquito infection rate (proportion of infected mosqui-
toes, i.e., proportion of mosquitoes with ≥  one oocyst) 
was 12.4% (3.4–32.6). Gametocyte levels were lower in 
non-infectious versus infectious individuals (Additional 
file 2: Figure S2), and correlated with mosquito infection 
rates (Spearman’s rank correlation coefficient 0.59, 0.62 
and 0.64 (P < 0.001 for all assays) for qRT-PCR, micros-
copy and QT-NASBA, respectively). Statistical models 
including log-transformed gametocyte levels estimated 
by QT-NASBA or microscopy explained a slightly higher 
proportion (marginal R2  =  0.28 and 0.26, respectively) 
of infectiousness variability compared to models includ-
ing log-transformed densities by qRT-PCR (marginal 
R2 = 0.22) (Fig. 3).
Lower‑than‑expected gametocyte densities in molecular 
assays
Venous samples collected from 77/79 children par-
ticipating in mosquito feeding experiments in Burkina 
Faso were also analysed. Of these 77 children, 27 did 
not carry microscopically detectable gametocyte densi-
ties on the day of their membrane feeding assay, despite 
having gametocytes detected by microscopy during 
the screening phase of the study (one to three days ear-
lier). Median (IQR) gametocyte density determined by 
microscopy was 12 (0–24) gametocytes per μL. Twenty 
of 77 did not have Pfs25 mRNA detected by qRT-PCR, 
and four had assigned gametocyte levels between 0 and 
0.02 gametocytes per μL, and were considered game-
tocyte negative. However, ten of these 24 children with 
no gametocytes detected by qRT-PCR had gametocytes 
detected by microscopy. Gametocyte densities estimated 
by QT-NASBA were also very low for most samples: 55 
children, including 31 with microscopically detectable 
gametocytes, had assigned levels below 0.02 gametocytes 
per μL (and were thus classified as gametocyte negative) 
and for one child of 76 Pfs25 mRNA was not detected. All 
23 samples with no Pfs25 mRNA amplification or with 
densities below 0.02 gametocytes per μL by qRT-PCR 
and that were also tested by QT-NASBA had assigned 
densities below 0.02 gametocytes per μL by this method. 
Considering that all these children had microscopically 
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Fig. 2 Bland-Altman plots to assess agreement between light 
microscopy, QT-NASBA and qRT-PCR levels in samples from naturally 
infected individuals. In the y-axes, differences between gametocyte 
levels estimated by two different methods are presented: a QT-
NASBA levels minus microscopy-defined densities, b qRT-PCR minus 
microscopy levels, c qRT-PCR levels minus levels estimated by QT-
NASBA. The X-axes present the average of the densities estimated by 
the two methods included in the calculation of the respective Y-axes. 
In panel a, the differences (Y-axis) are limited to a narrower range of 
values compared to panels b and c, and the inset plot presents the 
same data using different Y-axis limits
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detectable gametocytes one to three days before sample 
collection, it is likely that RNA material was of insuf-
ficient quality. It is highly plausible that freeze–thaws 
with unknown duration or frequency have affected 
RNA integrity of this set of samples, all kept in the same 
box throughout the storage period and shipment. The 
infectivity of study participants in the clinical trial in 
Burkina Faso was lower than the infectivity of individu-
als enrolled in the Malian study: 29/77 (37.6%) children 
infected at least one mosquito in feeding experiments. 
Although differences in the prevalence of host factors 
that influence infectivity, such as transmission-blocking 
immunity [25] or haemoglobinopathies [26], could have 
contributed to this observation, this disparity in infec-
tiousness prevalence is probably due to real differences 
in gametocyte levels as suggested by microscopy-based 
quantification and differences in the number of dissected 
mosquitoes (median number of mosquitoes dissected per 
assay, 142 and 45 in Mali and Burkina Faso, respectively). 
The facts that five of 29 and 17 of 29 individuals who 
infected mosquitoes did not have Pfs25 mRNA detected 
by qRT-PCR or had very low assigned levels (<0.02 game-
tocytes per μL) by QT-NASBA, respectively, and that 
the gametocyte density-mosquito infection rate plot is 
shifted to the left compared to the corresponding graph 
for the Malian study (Additional file 3: Figure S3) support 
the freeze–thaw explanation.
Discussion
In this study, Pfs25 mRNA QT-NASBA and qRT-PCR 
were evaluated using culture-derived gametocyte sam-
ples and samples from naturally infected individuals. In 
in  vitro experiments, both intra- and inter-assay varia-
tions were lower for qRT-PCR compared to QT-NASBA. 
When analysing samples from naturally infected indi-
viduals, gametocyte densities estimated by qRT-PCR 
were higher than densities estimated by QT-NASBA 
and microscopy in individuals with high gametocyte lev-
els. Gametocyte densities estimated by the two molecu-
lar assays, as well as by microscopy, correlated well with 
mosquito infection rates. Overall, the findings indicate 
that both assays are useful for quantifying sexual stage 
parasite densities in samples from naturally infected indi-
viduals, but qRT-PCR showed better reproducibility.
Determining the variability of quantitative assays is 
important for the interpretation of results. The experi-
ments here suggest that qRT-PCR has lower intra- 
and inter-assay variation compared to QT-NASBA. 
The higher precision of qRT-PCR is evident for the 
entire range of gametocyte densities used in the dilu-
tion series, despite involving extra reaction steps, such 
as DNase treatment and cDNA production, which are 
known to be a source of variation [27]. These two steps 
were performed once for each dilution series density, for 
the three different NF54 cultures and the NF135 and the 
NF166 cultures. There was considerably less between-
strain and -culture variation for similar densities in 
qRT-PCR versus QT-NASBA. In QT-NASBA reac-
tions, from the time of primer depletion, amplification 
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Fig. 3 Mosquito infection rates (y-axes), presented as proportions, by 
gametocyte counts (x-axes) in samples collected in a clinical study in 
Mali. Gametocyte densities were estimated by QT-NASBA (a), qRT-PCR 
(b) and light microscopy (c). Fitted curves and 95% confidence inter-
vals were estimated using glmmadmb package in R
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will mostly depend on the initial number of transcripts, 
resulting in a linear increase of amplicons. This exact 
moment when amplification starts may differ between 
samples depending on when and how the enzyme 
is added into the reaction wells, which adds a level of 
uncertainty to this methodology [28]. The range of TTP 
values in dilution series is also sensitive to the KCl con-
centration in the mix, which requires regular optimiza-
tion with new targets, batches of primers or molecular 
beacons [29].
Despite qRT-PCR being a more precise method for 
gametocyte quantification, QT-NASBA might detect 
a larger number of very low gametocyte densities (<0.1 
gametocytes per μL). QT-NASBA was originally devel-
oped for highly sensitive qualitative detection. The 
apparent higher sensitivity of QT-NASBA compared to 
qRT-PCR may be explained by methodological differ-
ences: for QT-NASBA it is not necessary to dilute sam-
ples, in order to complete DNase treatment and cDNA 
production (Additional file 1: Figure S1) and the equiva-
lent of a larger volume of the original sample is therefore 
added into the final reaction in QT-NASBA compared 
to qRT-PCR. This additional dilution in the qRT-PCR 
protocol could be avoided by using column-based RNA 
extraction with on-column DNase digestion [6]. Also, 
while qRT-PCR, in the protocol used here, carries on 
for a set amount of 40 cycles, the QT-NASBA reaction 
is continuous at a stable temperature for the duration of 
90  min. This might allow for more sensitive amplifica-
tion of low numbers of transcripts, but could also lead to 
the detection of single stranded DNA, in cases in which 
genomic DNA has been degraded and exists in the sam-
ple in a single stranded form. A stringent cut-off den-
sity below which samples are considered negative must 
therefore be applied in QT-NASBA, as with all other 
molecular assays.
Whether qRT-PCR overestimates true gametocyte lev-
els or QT-NASBA and microscopy underestimate den-
sities is not clear. When qRT-PCR is compared with the 
other methods, high mean densities correspond to the 
qRT-PCR measurement being larger than the other meas-
urements. There are two possible reasons for observing 
this pattern: (1) qRT-PCR overestimates high gameto-
cyte concentrations; or, (2) qRT-PCR measurements have 
greater variability [30]. Since the in vitro experiments sug-
gest that qRT-PCR has lower variability than QT-NASBA, 
it is likely that qRT-PCR has an upward bias at high game-
tocyte concentrations (>100 gametocytes per μL). The 
overestimation is unlikely to be caused by residual DNA 
in the RNA samples used in the qRT-PCR analysis, as the 
success of the DNase treatment was tested for two to five 
samples per plate, with no amplification detected.
The value of molecular methods in detecting epide-
miologically relevant malaria infections is becoming 
increasingly well established. A recent meta-analysis 
comparing PCR, microscopy and rapid diagnostic test 
(RDT) sensitivities showed that on average RDTs detect 
less than half of PCR-positive P. falciparum infections, 
and microscopy detects slightly less infections than 
RDTs [8]. The density of these sub-microscopic infec-
tions and their concurrent gametocyte levels are of 
relevance in estimating the contribution to malaria 
transmission. For P. falciparum parasite density (includ-
ing asexual parasites and gametocytes), RNA-based QT-
NASBA was previously compared to DNA-based qPCR 
for the quantification of P. falciparum 18S RNA and 
DNA, respectively [13]. Another recent study, this time 
on Leishmania parasites, compared 18S rRNA-based 
quantification by qRT-PCR and QT-NASBA to 18S 
rRNA gene DNA-based detection with qPCR [31]. In the 
first study, QT-NASBA was found to be more conveni-
ent and equally applicable for quantification purposes as 
real-time PCR, with strong correlation with quantifica-
tion by microscopy and similar inter-assay variation to 
both methods [13]. In the second study, intra- and inter-
assay CV were deemed equal for all three molecular 
methods and qRT-PCR was preferred over the other two 
methods for convenience reasons [31]. One explanation 
for these conflicting conclusions is the method used for 
detection of the amplified target in QT-NASBA: in the 
study comparing Leishmania quantification, the electro-
chemiluminescence (ECL) read-out added to the general 
workload of the assay. Additionally, co-amplification 
with a known amount of quantitative (Q)-RNA, as was 
originally done for the quantification of the different 
gametocyte stages as well as the Leishmania parasites, 
added an extra factor to the analysis of results [12, 31]. 
The direct comparison to a standard curve with micro-
scopically determined density of parasites, in addition to 
the use of molecular beacons, simplified the quantifica-
tion process of QT-NASBA results [13]. As mentioned 
earlier in the context of assay sensitivity, also conveni-
ence-wise, an important advantage of QT-NASBA is that 
it can be performed directly on extracted NA.
Several factors, such as the type of anticoagulant used 
in sample collection and the storage conditions, might 
influence the outcome of molecular assays on sam-
ples [9, 32]. The analysis of samples from Burkina Faso 
provides indirect evidence for this: the extremely low 
assigned gametocyte levels, including in samples col-
lected from children with microscopically detectable 
gametocytes, suggest that these samples might have gone 
through more than one freeze-thaw cycle. In these situa-
tions, sample quality may be compromised: mRNA may 
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be degraded and, although abundant transcripts, such 
as Pfs25 mRNA, might still be detectable, quantification 
becomes less reliable [33]. Quantification of constitu-
tively expressed human RNA targets and comparison of 
transcript levels among samples is one method that could 
have confirmed whether RNA degradation occurred and 
is recommended for future studies where there is uncer-
tainty about sample integrity.
Ultimately, the goal in quantifying gametocytes is to 
indirectly estimate human infectivity, as mosquito feed-
ing assays are logistically complex and only a handful of 
research institutes currently have the infrastructure to 
perform these experiments in sub-Saharan Africa. In this 
study, it was observed that QT-NASBA- and microscopy-
defined densities explain a slightly higher proportion of 
the variation in infectivity compared to gametocyte levels 
assigned by qRT-PCR but this difference should be inter-
preted with caution. The statistical method used here to 
evaluate this relationship was recently employed to assess 
the association between viraemia and mosquito infection 
risk in feeding assays involving dengue-infected individu-
als [34]. While the sigmoidal curves estimated by these 
models seem to fit mosquito infection data well for QT-
NASBA and microscopy, it is possible that qRT-PCR-
defined high densities were overestimated (Fig.  2b) and 
that could possibly explain the poorer fit of the model 
for that assay. These comparisons are based on a statisti-
cal model. More complex models [35], allowing for more 
flexible sigmoidal curves, would be required to formally 
assess the shape of the association between gametocyte 
density and mosquito infection rates. The quantifica-
tion of other parasite (e.g., sex ratio) or host factors (e.g., 
transmission-blocking immune responses and haemato-
logical factors) that might influence infectivity is likely 
to improve the predictive value of these models [36]. Of 
note, the enrolment criterion of multiple gametocytes 
being observed by microscopy (two or more gametocytes 
per 500 WBC) makes it difficult to directly extrapolate 
these results to sub-microscopic infections. By defini-
tion, microscopy has no quantitative value in sub-patent 
infections and molecular methods will need to be used to 
characterize the gametocytaemia-infectivity curve at low 
gametocyte densities.
Despite being the most commonly used amplifica-
tion target for estimating mature P. falciparum gameto-
cytes counts, the use of Pfs25 transcripts for quantifying 
gametocyte densities has drawbacks. Pfs25 mRNA levels 
are much lower in male compared to female gameto-
cytes [11]. Although it is generally assumed, due to the 
female bias in sex ratios (4–5:1) in natural infections, that 
female gametocyte levels are a good surrogate for all-sex 
gametocytes counts, quantification of the less abundant 
male gametocyte-specific Pfs230p mRNA or other male 
targets would provide more accurate estimates of the 
total number of mature gametocytes as well as sex ratios 
[11], a factor known to influence infectiousness [37]. 
In addition to these targets, transcribed only in mature 
gametocytes, transcripts of other genes have been used 
for the study of sexual stage malaria: an alternative 
marker of female gametocytes is pfg377, the expression 
of which begins in the sequestered stage III [38]; a tra-
ditional marker for commitment to gametocytogenesis is 
Pfs16 [12, 39], which is present in all gametocyte stages. 
Another early marker of commitment is PfGEXP5, the 
expression of which starts in ring-stage parasites com-
mitted to gametocytogenesis, is a potentially useful tool 
to be used in studies aiming to identify factors influenc-
ing commitment to sexual stage [40]. For all of these tar-
gets, transcript detection is possible both by the more 
convenient QT-NASBA and by the more laborious but 
more reproducible qRT-PCR. Design of intron-spanning 
primers may close the gap between the attractiveness 
of both methods and retain the advantage of the more 
reproducible qRT-PCR [41].
Conclusion
Estimating the contribution of sub-microscopic infec-
tions to malaria transmission is a priority in the malaria 
elimination era. Molecular methods that can quantify 
gametocytes levels in microscopically undetectable infec-
tions come with a promise to improve understanding of 
malaria epidemiology [42]. qRT-PCR of Pfs25 mRNA is 
more reproducible compared to QT-NASBA. Gameto-
cyte densities estimated by both methods, and by micros-
copy, correlate well with infectiousness in untreated 
individuals. Although this analysis of field samples sug-
gest that these assays are suitable to quantify patent 
gametocyte levels, their use to understand the detectabil-
ity and infectivity of sub-microscopic gametocyte den-
sities is even more important. Future studies thus need 
to be designed to include individuals with sub-patent 
gametocyte levels to confirm the sensitivity, precision 
and relative merits of these assays. Precise quantification 
of gametocytes at very low levels is of relevance to deter-
mine if a threshold density is associated with infectivity 
provided molecular targets are informative of gameto-
cyte viability and not merely of density [43]. Importantly, 
neither of the two molecular methods is routinely used in 
areas where field studies are undertaken and both assays 
are highly dependent on sample RNA quality.
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